Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA LUPIN AUROBINDO PHARMA/
LUPIN
 
P/E (TTM) x 12.5 402.6 3.1% View Chart
P/BV x 1.1 2.8 38.0% View Chart
Dividend Yield % 2.0 0.5 372.2%  

Financials

 AUROBINDO PHARMA   LUPIN
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
LUPIN
Mar-22
AUROBINDO PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,0641,268 83.9%   
Low Rs584679 86.1%   
Sales per share (Unadj.) Rs400.3361.0 110.9%  
Earnings per share (Unadj.) Rs45.7-33.2 -137.6%  
Cash flow per share (Unadj.) Rs64.93.3 1,980.8%  
Dividends per share (Unadj.) Rs9.004.00 225.0%  
Avg Dividend yield %1.10.4 265.7%  
Book value per share (Unadj.) Rs419.4263.9 159.0%  
Shares outstanding (eoy) m585.94454.48 128.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.12.7 76.4%   
Avg P/E ratio x18.0-29.3 -61.5%  
P/CF ratio (eoy) x12.7296.8 4.3%  
Price / Book Value ratio x2.03.7 53.3%  
Dividend payout %19.7-12.0 -163.5%   
Avg Mkt Cap Rs m482,799442,238 109.2%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50929,893 115.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555164,055 143.0%  
Other income Rs m3,2262,137 151.0%   
Total revenues Rs m237,781166,192 143.1%   
Gross profit Rs m42,5662,152 1,977.6%  
Depreciation Rs m11,26516,587 67.9%   
Interest Rs m4861,428 34.1%   
Profit before tax Rs m34,040-13,726 -248.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2561,372 529.1%   
Profit after tax Rs m26,784-15,097 -177.4%  
Gross profit margin %18.11.3 1,383.2%  
Effective tax rate %21.3-10.0 -213.3%   
Net profit margin %11.4-9.2 -124.1%  
BALANCE SHEET DATA
Current assets Rs m181,227124,577 145.5%   
Current liabilities Rs m81,56082,764 98.5%   
Net working cap to sales %42.525.5 166.7%  
Current ratio x2.21.5 147.6%  
Inventory Days Days2533 75.7%  
Debtors Days Days6295 65.8%  
Net fixed assets Rs m155,10491,938 168.7%   
Share capital Rs m586909 64.5%   
"Free" reserves Rs m245,174119,006 206.0%   
Net worth Rs m245,760119,915 204.9%   
Long term debt Rs m2,4921,419 175.7%   
Total assets Rs m336,331216,515 155.3%  
Interest coverage x71.0-8.6 -824.1%   
Debt to equity ratio x00 85.7%  
Sales to assets ratio x0.70.8 92.0%   
Return on assets %8.1-6.3 -128.4%  
Return on equity %10.9-12.6 -86.6%  
Return on capital %13.9-10.1 -137.2%  
Exports to sales %31.10-   
Imports to sales %11.90-   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,965NA-   
Fx inflow Rs m77,24553,594 144.1%   
Fx outflow Rs m31,52438,143 82.6%   
Net fx Rs m45,72115,451 295.9%   
CASH FLOW
From Operations Rs m50,1653,673 1,365.7%  
From Investments Rs m-32,11612,922 -248.5%  
From Financial Activity Rs m-29,693-15,723 188.8%  
Net Cashflow Rs m-11,674872 -1,338.5%  

Share Holding

Indian Promoters % 48.8 46.8 104.1%  
Foreign collaborators % 3.1 0.3 1,096.4%  
Indian inst/Mut Fund % 38.0 41.4 91.6%  
FIIs % 21.4 13.8 155.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 52.9 91.1%  
Shareholders   358,459 378,011 94.8%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    ZYDUS LIFESCIENCES    SANOFI INDIA    


More on Aurobindo Pharma vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Lupin Share Price Performance

Period Aurobindo Pharma Lupin S&P BSE HEALTHCARE
1-Day -1.08% -0.48% 0.15%
1-Month -16.15% 8.19% -1.70%
1-Year -35.59% -15.42% -6.84%
3-Year CAGR 0.44% -0.20% 20.62%
5-Year CAGR -8.06% -2.16% 10.61%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Lupin the stake stands at 47.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at -12.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 389 Points | Nifty Today Ends Below 18,500 | IT Stocks Witness Selling Pressure(Closing)

After opening the day on a flat note, Indian shares reversed early gains to end the day 0.6% lower.